Encyclopedia of Signaling Molecules

Living Edition
| Editors: Sangdun Choi


  • Arnauld Belmer
  • Selena E. Bartlett
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6438-9_101535-1


Historical Background

The first evidence of an active transport of serotonin (5-hydroxytryptamine, 5-HT) came from pioneer studies in the late 1950s showing an uptake of 5-HT into the blood platelets from rabbit or guinea pig. A few years later, a similar mechanism was observed in the rat brain (Schanberg 1963). The mechanism of this transport, involving the sodium and potassium ionic gradients, was rapidly elucidated, and the existence of a dedicated transporter protein postulated. In addition, the antidepressant imipramine was shown to bind to this putative transporter to reduce 5-HT uptake into the blood platelet, and, therefore, the serotonin transporter was named the “serotonin transporter-imipramine receptor.” Using the binding properties of imipramine to the serotonin transporter, Jane Talvenheimo and Gary Rudnick have purified the transporter...


Serotonin Transporter polyA Signal Reuptake Activity Extracellular Vestibule Transcription Factor CTCF 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 1993;15(3):243–5.CrossRefPubMedGoogle Scholar
  2. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 1998;44(3):169–78.CrossRefPubMedGoogle Scholar
  3. Brown P, Molliver ME. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci. 2000;20(5):1952–63.PubMedGoogle Scholar
  4. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 2003;4(12):1002–12.CrossRefPubMedGoogle Scholar
  5. Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins. Biochem Soc Trans. 2001;29(Pt 6):722–8.CrossRefPubMedGoogle Scholar
  6. Jess U, El Far O, Kirsch J, Betz H. Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C. Biochem Biophys Res Commun. 2002;294(2):272–9.Google Scholar
  7. Krishnan V, Nestler EJ. Animal models of depression: molecular perspectives. Curr Top Behav Neurosci. 2011;7:121–47.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Murphy DL, Moya PR. Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease. Curr Opin Pharmacol. 2011;11(1):3–10.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Quick MW. Regulating the conducting states of a mammalian serotonin transporter. Neuron. 2003;40(3):537–49.CrossRefPubMedGoogle Scholar
  10. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem. 1998;273(4):2458–66.CrossRefPubMedGoogle Scholar
  11. Ramamoorthy S, Samuvel DJ, Buck ER, Rudnick G, Jayanthi LD. Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J Biol Chem. 2007;282(16):11639–47.CrossRefPubMedGoogle Scholar
  12. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci. 2005;25(1):29–41.CrossRefPubMedGoogle Scholar
  13. Schanberg SM. A study of the transport of 5-hydroxytryptophan and 5-hydroxytryptamine (serotonin) into brain. J Pharmacol Exp Ther. 1963;139:191–200.PubMedGoogle Scholar
  14. Talvenheimo J, Rudnick G. Solubilization of the platelet plasma membrane serotonin transporter in an active form. J Biol Chem. 1980;255(18):8606–11.PubMedGoogle Scholar
  15. Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4(1):13–25.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  1. 1.Institute of Health and Biomedical Innovation (IHBI)Queensland University of Technology (QUT)BrisbaneAustralia